✦ LIBER ✦

Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes

✍ Scribed by Henke, Brad R.

Book ID: 126121289
Publisher: American Chemical Society
Year: 2004
Tongue: English
Weight: 238 KB
Volume: 47
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm030631e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peroxisome Proliferator-Activated Recept

Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes.

✍ Brad R. Henke 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

Discovery of a Novel Series of Peroxisom

Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia

✍ Liu, Kun; Xu, Libo; Berger, Joel P.; MacNaul, Karen L.; Zhou, Gauchao; Doebber, 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 98 KB

Dual Peroxisome Proliferator-Activated R

Dual Peroxisome Proliferator-Activated Receptor-α/γ Agonists

✍ Dr Harrihar A. Pershadsingh 📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 260 KB

The Art of Drug Synthesis || Peroxisome

The Art of Drug Synthesis || Peroxisome Proliferator-Activated Receptor (PPAR) Agonists for Type 2 Diabetes

✍ Johnson, Douglas S.; Li, Jie Jack 📂 Article 📅 2007 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 351 KB

The Role Of Medicinal Chemistry In Drug Discovery / John A. Lowe Iii -- Process Research: How Much? How Soon? / Neal G. Anderson -- Aromatase Inhibitors For Breast Cancer : Exemestane (aromasin), Anastrozole (arimidex), And Letrozole (femara) / Jie Jack Li -- Quinolone Antibiotics : Levofloxacin (le

Design and Synthesis of α-Aryloxy-α-meth

Design and Synthesis of α-Aryloxy-α-methylhydrocinnamic Acids: A Novel Class of Dual Peroxisome Proliferator-Activated Receptor α/γ Agonists

✍ Xu, Yanping; Rito, Christopher J.; Etgen, Garret J.; Ardecky, Robert J.; Bean, J 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 94 KB

Discovery of a Peroxisome Proliferator A

Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia

✍ Liu, Weiguo; Liu, Kun; Wood, Harold B.; McCann, Margaret E.; Doebber, Thomas W.; 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 373 KB